# Safety evaluation of the food enzyme aspergillopepsin I from the non‐genetically modified Aspergillus sp. strain AE‐PRHF

**Authors:** Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L. M. Solano, Henk Van Loveren, Laurence Vernis, Natália Kovalkovičová, Daniele Cavanna, Cristina Fernàndez‐Fraguas, Simone Lunardi, Silvia Peluso, Yi Liu

PMC · DOI: 10.2903/j.efsa.2025.9561 · 2025-07-14

## TL;DR

This study evaluates the safety of aspergillopepsin I, a food enzyme produced by a non-genetically modified Aspergillus strain, for use in food manufacturing.

## Contribution

The study provides a comprehensive safety assessment of aspergillopepsin I, including toxicity and allergenicity evaluations.

## Key findings

- Dietary exposure to the enzyme was estimated at up to 2.172 mg TOS/kg body weight per day in European populations.
- Genotoxicity tests showed no safety concerns, and the no observed adverse effect level was 2003 mg TOS/kg bw per day.
- A risk of allergic reactions cannot be excluded, but the likelihood is considered low.

## Abstract

The food enzyme aspergillopepsin I (EC 3.4.23.18) is produced with the non‐genetically modified Aspergillus sp. strain AE‐PRHF by AMANO ENZYME INC. The food enzyme was free from viable cells of the production organism. It is intended to be used in 15 food manufacturing processes. Since residual amounts of food enzyme–total organic solids (TOS) are removed in two processes, dietary exposure was calculated for the remaining 13 food manufacturing processes. It was estimated to be up to 2.172 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not indicate a safety concern. The systemic toxicity was assessed by means of a repeated dose 90‐day oral toxicity study in rats. The Panel identified a no observed adverse effect level of 2003 mg TOS/kg bw per day, the highest dose tested, which when compared with the estimated dietary exposure, resulted in a margin of exposure of at least 922. A search for the homology of the amino acid sequence of the aspergillopepsin I to known allergens was made and matches with three respiratory allergens and one injected allergen were found. The Panel considered that a risk of allergic reactions upon dietary exposure to the food enzyme cannot be excluded, but that the likelihood is low. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.

## Linked entities

- **Species:** Aspergillus sp. (taxon 5065), Rattus norvegicus (taxon 10116)

## Full-text entities

- **Diseases:** toxicity (MESH:D064420), allergic reactions (MESH:D004342)
- **Chemicals:** AMANO ENZYME INC (-)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Aspergillus sp. (species) [taxon 5065]

---
Source: https://tomesphere.com/paper/PMC12256987